Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Therapeutics and Clinical Risk Management|April 7, 2022
Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and PerspectivesGalina Tsykunova, Waleed GhanimaExpert Review of Clinical Immunology|January 6, 2025
Infectious complications and the utility of serum and cellular markers of infections in the setting of allogeneic hematopoietic stem cell transplantationHåkon Reikvam, Galina Tsykunova, Miriam Sandnes, et al.Expert Review of Hematology|August 20, 2019
Trisomy 8 in acute myeloid leukemiaAnette Lodvir Hemsing, Randi Hovland, Galina Tsykunova, et al.Expert Opinion on Drug Discovery|July 28, 2017
Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategiesØystein Bruserud, Elise Aasebø, Maria Hernandez-Valladares, et al.Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell TransplantationØystein Bruserud, Galina Tsykunova, Maria Hernandez-Valladares, et al.Expert Opinion on Investigational Drugs|March 20, 2012
Targeting of polo-like kinases and their cross talk with Aurora kinases--possible therapeutic strategies in human acute myeloid leukemia?Galina Tsykunova, Håkon Reikvam, Aymen Bushra Ahmed, et al.Expert Review of Clinical Immunology|January 6, 2017
Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatmentIda Sofie Grønningsæter, Galina Tsykunova, Kyrre Lilleeng, et al.Case Reports in Hematology|February 2, 2026
Relapse of Acute Myeloid Leukemia With Concomitant Systemic Mastocytosis Five Years Post Allogenic Hematopoietic Stem Cell TransplantationSona Vardanyan, Hilde K Gjelberg, Lars Helgeland, et al.Clinical Epigenetics|August 7, 2013
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemiaHanne Fredly, Elisabeth Ersvær, Astrid Olsnes Kittang, et al.Hematology (Amsterdam, Netherlands)|December 11, 2023
Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantationGalina Tsykunova, Erle Kristensen, Asbjørg Stray-Pedersen, et al.Pageof 2